BrainsWay Ltd.
NASDAQ:BWAYMedical - Devices
+$0.05 today
- Market cap
- $352.22M
- Beta
- 0.15
- P/E (TTM)
- 61.7
- EPS (TTM)
- $0.23
Volume 0.15M
Average 0.15M
BWAY Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
BrainsWay Ltd.NASDAQ: BWAY
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue growth accelerates
Q1 FY2026 revenue of $15.53M rose 34.6% year over year, ahead of the +29.4% change in trailing-twelve-month revenue. Sequentially, it rose 6.8% from the prior quarter. Over 3 fiscal years it compounded at +24.3% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 2 analysts of $69.78M (+33.6%) for the fiscal year ending Dec 2026, a step up from the +27.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $15.53M+6.8% QoQ
- Last fiscal yearDec 2025
- $52.23M+27.3% YoY
- LTMMar 2026
- $56.22M+29.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +34.6% | +31.0% | -3.7 pp |
| 1 year | +27.3% | +33.6% | +6.3 pp |
| 3-year CAGR | +24.3% | +24.9% | +0.6 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 52.23M USD
- Year-over-year change
- +27.3%
- 4-year CAGR
- +15.2%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 52.23M | +27.3% |
| FY2024 | 2024-12-31 | 41.02M | +29.0% |
| FY2023 | 2023-12-31 | 31.79M | +17.0% |
| FY2022 | 2022-12-31 | 27.18M | -8.4% |
| FY2021 | 2021-12-31 | 29.66M | — |
Revenue vs competitors
How BWAY compares with its peers on the latest reported figures
- BWAY's LTM Mar 2026 revenue of $56.22M is the 3rd highest of the 4 companies compared; the peer median is $99.53M.
- Its year-over-year change of +29.4% is the 3rd highest of 4, against a peer median of +69.5%.
- Over three fiscal years its annual growth of +24.3% compares with a peer median of +31.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $151.64M | +69.5% | +31.8% | |
| LTM Mar 2026 | $99.53M | +18.1% | +30.0% | |
| LTM Mar 2026 | $56.22M | +29.4% | +24.3% | |
| LTM Mar 2026 | $9.59M | +2109.4% | +97.0% | |
MOBIMobia Medical, Inc. Common Stock | — | — | — | — |
| Peer median (excluding BWAY) | $99.53M | +69.5% | +31.8% | |
Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 29.66M | 27.18M | 31.79M | 41.02M | 52.23M |
| Cost of Revenue | 6.6M | 7.13M | 8.31M | 10.44M | 12.84M |
| Gross Profit | 23.06M | 20.05M | 23.48M | 30.58M | 39.39M |
| Gross Margin | 77.7% | 73.8% | 73.9% | 74.6% | 75.4% |
| Research & Development | 6.39M | 7.68M | 6.67M | 7.19M | 9.6M |
| Selling, General & Admin | 21.66M | 25.05M | 21.64M | 22M | 25.46M |
| Operating Expenses | 28.06M | 32.73M | 28.44M | 29.19M | 35.06M |
| Depreciation & Amortization | 1.69M | 1.53M | 1.34M | 1.77M | 1.54M |
| EBITDA | (4.67M) | (11.45M) | (2.56M) | 5.36M | 11.46M |
| EBITDA Margin | -15.8% | -42.1% | -8.1% | 13.1% | 21.9% |
| Operating Income | (5M) | (12.68M) | (4.96M) | 1.39M | 4.32M |
| Operating Margin | -16.9% | -46.7% | -15.6% | 3.4% | 8.3% |
| Interest Income | 225K | 1.11M | 2.17M | 2.48M | 5.64M |
| Interest Expense | 141K | 68K | 298K | 1.36M | 2.23M |
| Other Income / Expenses | (1.42M) | (351K) | 1.01M | 2.07M | 3.39M |
| Income Before Tax | (6.42M) | (13.03M) | (3.95M) | 3.46M | 7.71M |
| Pre-Tax Margin | -21.6% | -48.0% | -12.4% | 8.4% | 14.8% |
| Income Tax Expense | 43K | 315K | 251K | 538K | 77K |
| Net Income | (6.46M) | (13.35M) | (4.2M) | 2.92M | 7.63M |
| Net Margin | -21.8% | -49.1% | -13.2% | 7.1% | 14.6% |
| EPS (Basic) | (0.21) | (0.43) | (0.13) | 0.09 | 0.40 |
| EPS (Diluted) | (0.21) | (0.43) | (0.13) | 0.09 | 0.36 |
| Weighted Avg Shares | 31.15M | 32.98M | 33.16M | 33.97M | 19.08M |
| Weighted Avg Shares (Diluted) | 31.15M | 32.98M | 33.16M | 34.77M | 21.21M |
BrainsWay Ltd.
NASDAQ:BWAY
Intrinsic Alpha fair value
Locked
Current Price
$8.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.